Acute Hepatitis Due to Epstein Barr Virus with Cross-Reacting Antibodies to Cytomegalovirus

被引：2

作者：

Karadeniz, Asli ^{[1
]}

Yesilbag, Zuhal ^{[4
]}

Kaya, Fatih Oner ^{[2
]}

Akgun, Feride Sinem ^{[3
]}

机构：

[1] Maltepe Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Feyzullah Rd 39, TR-34843 Istanbul, Turkey

[2] Maltepe Univ, Fac Med, Dept Internal Med, Istanbul, Turkey

[3] Maltepe Univ, Fac Med, Dept Emergency Med, Istanbul, Turkey

[4] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey

来源：

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY | 2018年 / 36卷 / 01期

关键词：

Acute hepatitis; cytomegalovirus; Epstein-Barr virus; CASE SERIES;

D O I：

10.4103/ijmm.IJMM_17_378

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Epstein Ban virus (EBV) is the cause of systemic infection known as infectious mononucleosis with classic presentation of fever, oropharyngitis and lymphadenitis. EBV rarely causes acute hepatitis. in this report, we present a 19-year-old patient presented with nausea, fatigue and jaundice. Her physical examination and laboratory tests revealed the diagnosis as acute hepatitis due to EBV with cross-reacting antibodies to cytomegalovirus.

引用

页码：143 / 144

页数：2

共 50 条

[1] Epstein-barr virus associated acute hepatitis with cross-reacting antibodies to other herpes viruses in immunocompetent patients: Report of two cases
Gupta, Ekta
Bhatia, Vikram
Choudhary, Aashish
Rastogi, Archana
Gupta, Naveen L.
JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (03) : 519 - 523
[2] Acute Hepatitis Due to Epstein–Barr Virus in an Immunocompetent Patient
Neha Pagidipati
Keith L. Obstein
Rachel Rucker-Schmidt
Robert D. Odze
Christopher C. Thompson
Digestive Diseases and Sciences, 2010, 55 : 1182 - 1185
[3] Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes
Leonardsson, Hilmar
Hreinsson, Johann Pall
Love, Arthur
Bjornsson, Einar S.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (08) : 893 - 897
[4] The Antibody Response to Autoantigens Cross-reacting with Epstein-Barr Virus Decreases During Ocrelizumab Treatment
Lindsey, J. W.
Pham, H. P.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 184 - 185
[5] Acute Hepatitis Due to Epstein-Barr Virus in an Immunocompetent Patient
Pagidipati, Neha
Obstein, Keith L.
Rucker-Schmidt, Rachel
Odze, Robert D.
Thompson, Christopher C.
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) : 1182 - 1185
[6] HEPATITIS DUE TO CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS: A POPULATION-BASED STUDY
Bjornsson, Einar
Leonardsson, Hilmar
Love, Arthur
GASTROENTEROLOGY, 2017, 152 (05) : S1162 - S1162
[7] Cross-Reacting Antibodies in Xenotransplantation
Habibabady, Zahra
Kinoshita, Kohei
Hara, Hidetaka
Pierson, Richard N., III
Cooper, David K. C.
TRANSPLANTATION, 2022, 106 (09) : S426 - S426
[8] CHARACTERIZATION OF CROSS-REACTING ANTIGENS ON THE EPSTEIN-BARR VIRUS ENVELOPE AND PLASMA-MEMBRANES OF PRODUCER CELLS
THORLEYLAWSON, DA
JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1979, : 213 - 213
[9] Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, Wanwisa
Jumnainsong, Amonrat
Onsirisakul, Naruthai
Fitton, Patricia
Vasanawathana, Sirijitt
Limpitikul, Wannee
Puttikhunt, Chunya
Edwards, Carolyn
Duangchinda, Thaneeya
Supasa, Sunpetchuda
Chawansuntati, Kriangkrai
Malasit, Prida
Mongkolsapaya, Juthathip
Screaton, Gavin
SCIENCE, 2010, 328 (5979) : 745 - 748
[10] Report of eight cases of acute hepatitis due to Epstein-Barr virus
Maria Prieto de Paula, Jose
Mayor Toranzo, Eduardo
Franco Hidalgo, Silvia
GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (02): : 103 - 105

← 1 2 3 4 5 →